Vesicular stomatitis virus M protein in the nuclei of infected cells.
about
Nuclear localization of Semliki Forest virus-specific nonstructural protein nsP2A confocal and electron microscopic comparison of interferon beta-induced changes in vesicular stomatitis virus infection of neuroblastoma and nonneuronal cells.Membrane-binding domains and cytopathogenesis of the matrix protein of vesicular stomatitis virus.ANP32B is a nuclear target of henipavirus M proteins.The matrix protein of vesicular stomatitis virus inhibits nucleocytoplasmic transport when it is in the nucleus and associated with nuclear pore complexes.Inhibition of host transcription by vesicular stomatitis virus involves a novel mechanism that is independent of phosphorylation of TATA-binding protein (TBP) or association of TBP with TBP-associated factor subunits.Sites of in vivo phosphorylation of vesicular stomatitis virus matrix protein.Cytopathogenesis and inhibition of host gene expression by RNA viruses.Respiratory syncytial virus represses glucocorticoid receptor-mediated gene activation.Mutations in the glycoprotein of vesicular stomatitis virus affect cytopathogenicity: potential for oncolytic virotherapy.Tracking the Fate of Genetically Distinct Vesicular Stomatitis Virus Matrix Proteins Highlights the Role for Late Domains in Assembly.Inducible and conditional inhibition of human immunodeficiency virus proviral expression by vesicular stomatitis virus matrix protein.Vesicular stomatitis virus infection induces a nuclear DNA-binding factor specific for the interferon-stimulated response element.The vesicular stomatitis virus matrix protein inhibits transcription from the human beta interferon promoterLarge-Scale Screening and Identification of Novel Ebola Virus and Marburg Virus Entry InhibitorsEffect of vesicular stomatitis virus matrix protein on host-directed translation in vivoThe role of vesicular stomatitis virus matrix protein in inhibition of host-directed gene expression is genetically separable from its function in virus assembly.Plasma membrane microdomains containing vesicular stomatitis virus M protein are separate from microdomains containing G protein and nucleocapsidsInfectious Entry Pathway Mediated by the Human Endogenous Retrovirus K Envelope Protein.Vesicular stomatitis virus matrix protein inhibits host cell-directed transcription of target genes in vivoKaryophilic properties of Semliki Forest virus nucleocapsid proteinSolubility of vesicular stomatitis virus M protein in the cytosol of infected cells or isolated from virionsMigration of Nucleocapsids in Vesicular Stomatitis Virus-Infected Cells Is Dependent on both Microtubules and Actin FilamentsVesicular stomatitis virus matrix protein mutations that affect association with host membranes and viral nucleocapsidsThe respiratory syncytial virus matrix protein possesses a Crm1-mediated nuclear export mechanism.Endocytosis of murine norovirus 1 into murine macrophages is dependent on dynamin II and cholesterol.Vesicular stomatitis virus pseudotyped with Ebola virus glycoprotein serves as a protective, non-infectious vaccine against Ebola virus challenge in mice.Intracellular distribution of input vesicular stomatitis virus proteins after uncoating.Nuclear entry and nucleolar localization of the Newcastle disease virus (NDV) matrix protein occur early in infection and do not require other NDV proteins.Mutation of YMYL in the Nipah virus matrix protein abrogates budding and alters subcellular localization.Murine norovirus-1 entry into permissive macrophages and dendritic cells is pH-independent.Preservation of dendritic cell function during vesicular stomatitis virus infection reflects both intrinsic and acquired mechanisms of resistance to suppression of host gene expression by viral M protein.Nuclear transport of plant potyviral proteins.Reconstruction of the cell entry pathway of an extinct virus
P2860
Q27486583-D5A7D93A-575F-4F44-B431-34A46D88560CQ30436826-3C013933-3E4B-4696-8480-279E75C3D1DEQ30452104-C5F70E69-7A20-44B4-A985-083794AE6165Q33604691-3D288C28-D975-4A53-8EDB-0FFE0A9FBD72Q33605916-B17B0263-BC20-43C8-B698-D5F8F01B064BQ33840103-D1389761-FA17-4835-9B40-B705345712FFQ33935589-BB4D5327-CE36-4A1F-A4E9-6946C25D5B66Q34010277-E81FD827-03DC-4796-AB7D-793C31EFC4F7Q34566553-A86A6A19-655B-40D6-AF27-C173460D51CEQ35077419-4E6BB0B7-23E2-496A-9706-1E670330B32EQ35764360-BBF27383-C9E7-456B-BBAA-2ADD182E4F2BQ35839778-3E82471A-0747-449A-B0CC-876A6DD79102Q35841177-C6822FDC-69AD-430F-8FEE-FD96AA3DB6D3Q35874889-C18C4D4D-9896-46D8-828A-5102F2900763Q36012840-ACCB2D8C-C68A-4EA1-94E0-E774D0AA6C67Q36620840-B01AA2DE-8AD4-4E83-88DC-1EE19CD643FAQ36651213-47CF4C10-9449-4259-B64D-6DCCE8D0597EQ36673397-731CDE1B-8AFE-41AB-A426-5EB1CE807DB3Q36694049-9B72EC1A-034C-46D0-8339-10995D572B87Q36698715-429368B1-7355-4429-997D-E2FDE8A9DE11Q36784306-B3DF0899-5090-4A5E-B4A7-4D8229060602Q36801348-E17F0FB3-DF27-489A-9393-AC7069F22491Q37002579-1F1315E4-4BCB-4192-99C4-91A90DF059E0Q37094187-7D35EF29-414B-45DE-A60C-1245696B4A6CQ37191929-CABF6A5C-FD74-49FB-9C3A-8E5EFA2A79FCQ39717486-DD171585-F407-43DB-8AD3-D28EC4B71184Q40052567-9C7AE971-C6E9-4FB1-AA17-DED455C0F623Q40063108-B4DBC420-D4D5-4DB3-B21C-8D2419E0BED7Q40065614-ACC3D91D-C770-45E9-9716-893F53622858Q40226883-60FAB1F9-1D26-4F23-9103-5240F7B1761CQ41938323-0BF8A43C-4384-442F-8DAE-923316544962Q42273541-4F1540EE-3B93-4488-AA9C-40C2D6DC7BE4Q43765680-B2060226-0CAF-48C2-863B-6CEFB91FF868Q57001224-BC8120D7-636A-4AE0-8ADC-C449D956DBCB
P2860
Vesicular stomatitis virus M protein in the nuclei of infected cells.
description
1988 nî lūn-bûn
@nan
1988年の論文
@ja
1988年論文
@yue
1988年論文
@zh-hant
1988年論文
@zh-hk
1988年論文
@zh-mo
1988年論文
@zh-tw
1988年论文
@wuu
1988年论文
@zh
1988年论文
@zh-cn
name
Vesicular stomatitis virus M protein in the nuclei of infected cells.
@en
type
label
Vesicular stomatitis virus M protein in the nuclei of infected cells.
@en
prefLabel
Vesicular stomatitis virus M protein in the nuclei of infected cells.
@en
P2093
P2860
P1433
P1476
Vesicular stomatitis virus M protein in the nuclei of infected cells.
@en
P2093
B J McCreedy
L Puddington
P2860
P304
P407
P577
1988-11-01T00:00:00Z